| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $151.9M | +31.4% |
| Cost of Revenue | $122.1M | +29.2% |
| Gross Profit | $29.8M | +41.3% |
| R&D Expense | $779K | +433.1% |
| SG&A Expense | $37.1M | +77.1% |
| Operating Income | -$13.9M | -204.1% |
| Pre-tax Income | -$13.5M | -177.9% |
| Income Tax | $1.3M | +3.0% |
| Net Income | -$14.8M |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.1M | -13.0% |
| Accounts Receivable | $59.7M | +143.6% |
| Inventory | $6.4M | -14.8% |
| Current Assets | $102.6M | +20.9% |
| Total Assets | $122.6M | +35.2% |
| Current Liabilities | $86.0M | +53.7% |
| Total Liabilities | $88.2M | +48.7% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.3M | -141.4% |
| Capital Expenditures | $2.0M | +93.0% |
| Investing Cash Flow | $3.0M | +129.4% |
| Financing Cash Flow | $10.1M | +161.3% |
| Free Cash Flow | -$20.3M | -135.7% |
| -142.2% |
| EPS (Basic) | -$0.27 | -125.0% |
| EPS (Diluted) | -$0.27 | -125.0% |
| Stockholders' Equity |
| $34.5M |
| +9.8% |